- Home
- CRIS vs GTIM Comparison
CRIS vs GTIM Comparison
Compare CRIS & GTIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- GTIM
- Stock Information
- Founded
- CRIS 2000
- GTIM 1987
- Country
- CRIS United States
- GTIM United States
- Employees
- CRIS N/A
- GTIM N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- GTIM Restaurants
- Sector
- CRIS Health Care
- GTIM Consumer Discretionary
- Exchange
- CRIS Nasdaq
- GTIM Nasdaq
- Market Cap
- CRIS 32.8M
- GTIM N/A
- IPO Year
- CRIS 2000
- GTIM 1990
- Fundamental
- Price
- CRIS $1.48
- GTIM $2.41
- Analyst Decision
- CRIS Strong Buy
- GTIM
- Analyst Count
- CRIS 3
- GTIM 0
- Target Price
- CRIS $21.00
- GTIM N/A
- AVG Volume (30 Days)
- CRIS 51.0K
- GTIM 17.0K
- Earning Date
- CRIS 03-31-2025
- GTIM 05-01-2025
- Dividend Yield
- CRIS N/A
- GTIM N/A
- EPS Growth
- CRIS N/A
- GTIM N/A
- EPS
- CRIS N/A
- GTIM 0.21
- Revenue
- CRIS $10,908,000.00
- GTIM $145,491,000.00
- Revenue This Year
- CRIS N/A
- GTIM N/A
- Revenue Next Year
- CRIS $27.88
- GTIM N/A
- P/E Ratio
- CRIS N/A
- GTIM $11.54
- Revenue Growth
- CRIS 8.83
- GTIM 5.49
- 52 Week Low
- CRIS $1.42
- GTIM $2.25
- 52 Week High
- CRIS $17.49
- GTIM $3.45
- Technical
- Relative Strength Index (RSI)
- CRIS 18.52
- GTIM 51.16
- Support Level
- CRIS $2.57
- GTIM $2.32
- Resistance Level
- CRIS $2.62
- GTIM $2.54
- Average True Range (ATR)
- CRIS 0.26
- GTIM 0.13
- MACD
- CRIS -0.07
- GTIM 0.00
- Stochastic Oscillator
- CRIS 10.88
- GTIM 52.50
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.